| A Study to Characterize the Safety and Immunogenicity of AZD6489 in Participants 60 Years of Age and Older (ARIES) (NCT07717840) | AstraZeneca | 2026-07-08 |
| Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors (NCT07599176) | National Heart, Lung, and Blood Institute (NHLBI) | 2026-07-08 |
| Study of DCC-2618 in Patients With GIST After at Least 3 Prior Treatments (NCT07618377) | Ono Pharmaceutical Co., Ltd. | 2026-07-07 |
| Clinical Trial Evaluating the Safety and Efficacy of Chemoimmunotherapy Plus Short Course of Mek Inhibitor in First Line of Treatment of Metastatic Non Squamous Non Small Cell Lung Adenocarcinoma With PDL1 < 50 %. (NCT05937906) | Centre Georges Francois Leclerc | 2026-07-07 |
| Stem Cells for Erectile Dysfunction Post RALP (NCT07048314) | The Methodist Hospital Research Institute | 2026-07-07 |
| Cabotegravir-Hormone PK/PD Interactions for HIV Prevention (NCT07672717) | Johns Hopkins University | 2026-07-07 |
| A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Non-Small Cell Lung Cancer (NCT07623356) | Akeso | 2026-07-07 |
| Asciminib in HER2+ Breast Cancer Brain Metastases (NCT07136428) | Duke University | 2026-07-07 |
| First-Line Ipilimumab Plus Nivolumab and Nogapendekin Alfa Inbakicept (N-803) in Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer (NCT07355205) | Washington University School of Medicine | 2026-07-07 |
| A Study in Adult Males With X-linked Congenital Nephrogenic Diabetes Insipidus to Test the Effects of NDI-5001 Given for Multiple Days and to Test How NDI-5001 is Tolerated and Taken up in the Body (NCT07525960) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2026-07-07 |
| A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of LRK-4189 Alone and in Combination in Patients With Solid Tumors (NCT07498725) | LARKSPUR BIOSCIENCES, INC. | 2026-07-07 |
| Single Ascending Dose Study of ATH-097 in Healthy Participants (NCT07640269) | Atheron Therapeutics, Ltd. | 2026-07-06 |
| A Study of BL1332 on Capsaicin-Induced Ocular Pain in Healthy Trial Participants (NCT07717918) | Bausch & Lomb Incorporated | 2026-07-06 |
| Material Balance of [14C]Zorifertinib in Healthy Adult Male Participants in China (NCT07620951) | Alpha Biopharma (Jiangsu) Co., Ltd. | 2026-07-06 |
| Study of AHB-171 in Chronic Hepatitis B Participants (NCT07617194) | AusperBio Therapeutics Inc. | 2026-07-06 |
| Mass Balance Study of [14C] Flonoltinib Maleate (NCT07612306) | Chengdu Zenitar Biomedical Technology Co., Ltd | 2026-07-06 |
| A Study to See How Safe a New Medicine (NNC6022-0004) is in Healthy People and People Living With Obesity (NCT07693868) | Novo Nordisk A/S | 2026-07-06 |
| Universal STAR-T Cell Injection in Generalized Myasthenia Gravis (NCT07714798) | Daishi Tian | 2026-07-06 |
| Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL) (NCT07387926) | Novartis Pharmaceuticals | 2026-07-05 |
| A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors (NCT07600476) | Kupando GmbH | 2026-07-03 |
| A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of HLX319 vs. EU-Phesgo® in the Neoadjuvant Therapy of HER2-Positive Early or Locally Advanced Breast Cancer (NCT07601620) | Shanghai Henlius Biotech | 2026-07-03 |
| A Study to Investigate the Pharmacokinetics, Pharmacodynamics, and Safety of NKF-PEG, and US-Neulasta in Healthy Adult Male Volunteers (NCT07738991) | Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. | 2026-07-03 |
| Vebreltinib Plus Furmonertinib in Patients With EGFR-mutated Advanced Non-small Cell Lung Cancer and High PD-L1 Expression (NCT07655622) | Second Affiliated Hospital of Nanchang University | 2026-07-03 |
| Phase 1 Study Of LNK001 In Advanced Or Metastatic Clear Cell Renal Cell Carcinoma (NCT07564232) | M.D. Anderson Cancer Center | 2026-07-02 |
| A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01) (NCT07630974) | Merck Sharp & Dohme LLC | 2026-07-02 |
| A Study to Investigate the Difference In Blood Levels of Camlipixant Between Different Camlipixant Formulation Prototypes (NCT07684586) | GlaxoSmithKline | 2026-07-02 |
| A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS) (NCT07698899) | Memorial Sloan Kettering Cancer Center | 2026-07-02 |
| A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Enicepatide in Generally Healthy Adult Chinese Participants (NCT07626515) | Hoffmann-La Roche | 2026-07-02 |
| HY001N for Patients With Autoimmune Hemolytic Anemia After Failure ≥3 Lines of Therapy. (NCT07748533) | Juventas Cell Therapy Ltd. | 2026-07-02 |
| HJB647 Phase 1b Study in Japanese Healthy Participants With Elevated Blood Pressure and Patients With Hypertension (NCT07644364) | Novartis Pharmaceuticals | 2026-07-02 |
| A Mass Balance Study of [14C]HRS-9057 for Injection in Healthy Participants (NCT07681479) | Fujian Shengdi Pharmaceutical Co., Ltd. | 2026-07-01 |
| Safety, Tolerability and Pharmacokinetics of a Subcutaneous Semaglutide Implant (NCT07430059) | Vivani Medical, Inc | 2026-07-01 |
| BPI-361175 Tablets in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT05393466) | Xcovery Holdings, Inc. | 2026-07-01 |
| Abdominal aBscess Catheter Sclerotherapy (ABCS) (NCT06906029) | University of Alabama at Birmingham | 2026-07-01 |
| A Phase 1, Double-blind, Randomized Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Single Dose and Multiple Doses of CG-0416 in Healthy Participants. (NCT07724431) | HongKong Curegene Innovation Co., Limited | 2026-07-01 |
| A Feasibility Study of Supplemental Oxygen to Improve Pulmonary Hypertension in People With Intradialytic Hypoxemia (NCT06327373) | Duke University | 2026-07-01 |
| Assessing PI3K Gamma Inhibition With Azacitidine, Venetoclax and Eganelisib in Patients With Acute Myeloid Leukemia (NCT07439211) | Jacqueline Garcia, MD | 2026-07-01 |
| A Multicenter, Prospective, Randomized, Open-label Phase Ib/II Study of Celecoxib Plus Pembrolizumab and Gemcitabine/Cisplatin Versus Pembrolizumab and Gemcitabine/Cisplatin in Patients With CK5/6-High Unresectable Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma (NCT07632235) | Shanghai 6th People's Hospital | 2026-07-01 |
| Low Intensity Focused Ultrasound in ASD (NCT07225322) | Medical University of South Carolina | 2026-07-01 |
| Samuraciclib in Combination With Gemcitabine/Nab-Paclitaxel in Patients With Metastatic Basal-Like Pancreatic Cancer (NCT07665684) | University Health Network, Toronto | 2026-07-01 |
| Bioequivalence Study of AJU-G721 and G721R in Healthy Adult Volunteers Under Fed Conditions (NCT07643233) | AJU Pharm Co., Ltd. | 2026-07-01 |
| Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis Risk in Postmenopausal Females (NCT07365514) | University of Connecticut | 2026-07-01 |
| Study of Intrathecal ELP-02 for Charcot-Marie-Tooth Disease Type 4J (CMT4J) (NCT07447557) | Elpida Therapeutics SPC | 2026-07-01 |
| Topical Carboxytherapy Paste Following Microneedling (NCT07431541) | Vanderbilt University Medical Center | 2026-07-01 |
| Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma (NCT06492954) | Emory University | 2026-07-01 |
| Safety and Efficacy of Allogeneic Bone Marrow MSCs in Ankylosing Spondylitis (NCT07632599) | Eighth Affiliated Hospital, Sun Yat-sen University | 2026-07-01 |
| Targeting Collagen VII Antibodies in Bullous Diseases Using Efgartigimod IV (VYVGART) (NCT07011589) | M. Peter Marinkovich | 2026-07-01 |
| Rituximab for PTLD Prevention in Solid Organ Transplant Recipients With EBV DNAemia (NCT07614282) | Jennifer Amengual | 2026-07-01 |
| Study to Determine Optimal Dose, Evaluate the Efficacy and Safety of PRG-N-01 in Patients With Neurofibromatosis Type II (NCT07131722) | PRG Science & Technology Co., Ltd. | 2026-07-01 |
| A Surgical Procedure (Total Pancreatectomy) With a Transplant Procedure (Islet Cell Autotransplantation) for the Treatment of Chronic Pancreatitis and Benign Pancreatic Tumors (NCT05453851) | OHSU Knight Cancer Institute | 2026-07-01 |
| C-CAR168 CAR T Cell Therapy for Refractory Autoimmune Disease (NCT06935474) | AbelZeta Inc. | 2026-07-01 |
| A Study of Eloralintide (LY3841136) in Healthy Participants (NCT07701083) | Eli Lilly and Company | 2026-07-01 |
| IL-8 Receptor Modified Patient-Derived Activated CD70 CAR T Cell Therapy in Adults With Brain Metastases (NCT07569263) | University of Florida | 2026-07-01 |
| A Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIV (NCT07698600) | BioNTech SE | 2026-07-01 |
| Time Restricted Eating in Patients With Microalbuminuria (NCT06884059) | University of California, San Diego | 2026-07-01 |
| A Study of [177Lu]Lu-A9-0631 and [225Ac]Ac-A9-0642 With [68Ga]Ga-A9-6217 or [177Lu]Lu-A9-0631 Imaging in GRPR+ Solid Tumors (NCT07661641) | Alpha-9 Oncology USA Inc. | 2026-07-01 |
| Randomized Double-blind Controlled Clinical Study of SGLT-2i Combined With Probiotic Preparations in Elderly Patients With HFpEF (NCT07687212) | The First Affiliated Hospital of Air Force Medicial University | 2026-07-01 |
| The Food Effect on Pharmacokinetics of Fixed Dose Combination of Gemigliptin/Dapagliflozin/Metformin in Healthy Volunteers (NCT07396844) | LG Chem | 2026-07-01 |
| Study of ECC4703 With Sulfasalazine and Pitavastatin (NCT07726368) | Eccogene | 2026-07-01 |
| A Study of CLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101) (NCT07650357) | Clasp Therapeutics, Inc. | 2026-07-01 |
| HEALTH Trial - Healthy Adult Evaluation of Ivermectin Bioequivalence: Infant Versus Standard Formulation (NCT06918665) | Murdoch Childrens Research Institute | 2026-07-01 |
| Phase I-II PTCy, Bortezomib and Sitagliptin for Prevention of GvHD Following Allogeneic HSCT (NCT07675174) | Northwell Health | 2026-07-01 |
| IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Newly Diagnosed and Recurrent Pediatric High-grade Glioma (pHGG) and Newly Diagnosed Diffuse Intrinsic Pontine Glioma (ndDIPG) (NCT06946680) | University of Florida | 2026-07-01 |
| BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire Disorder (NCT07596212) | University of Illinois at Chicago | 2026-07-01 |
| Fecal MicrobiotaTransplant for the Treatment of Parkinson's Disease (NCT06647277) | ProgenaBiome | 2026-07-01 |
| Preoperative Proton Irradiation for High-grade Brain Gliomas. (NCT07710040) | National Medical Research Radiological Centre of the Ministry of Health of Russia | 2026-07-01 |
| A Phase Ib Study of the Selective PKC-β Inhibitor MS-553 in Patients With Refractory or Relapsed CLL/SLL (NCT06979076) | MingSight Pharmaceuticals, Inc | 2026-07-01 |
| CD45RA-depleted DLI for the Prevention of Viral Infections in High-risk Patients After Haploidentical Transplantation (NCT07672964) | Ruijin Hospital | 2026-07-01 |
| A Study of FG-B901 Monotherapy or Combination With Chemotherapy in Advanced or Metastatic Solid Tumors (NCT07623707) | FutureGen Biopharmaceutical (Beijing) Co., Ltd | 2026-07-01 |
| A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy (NCT07676266) | The Affiliated Hospital of Qingdao University | 2026-07-01 |
| A Phase Ib/II Study of BM230 in Combination With PD-1 Inhibitor for HER2-related Advanced Solid Tumors (NCT07698587) | Suzhou Biomissile Pharmaceuticals Co., Ltd. | 2026-07-01 |
| Evaluate Pharmacokinetics, Safety, and Tolerability of AX251 LAI in Patients With Schizophrenia (NCT07484204) | Anxo Pharmaceutical Co., Ltd. | 2026-07-01 |
| CIB In Vivo CAR-T Lentiviral Injection in Patients With Advanced Malignant Tumors (NCT07657585) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2026-07-01 |
| A Prospective, Open-Label Study Evaluating the Effectiveness of Gepants for Acute Treatment of Migraine in the Emergency Department (NCT07667621) | University of South Florida | 2026-07-01 |
| A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight (NCT07738614) | Eli Lilly and Company | 2026-07-01 |
| A Study to Assess the Skin Irritation and Sensitization of Selegiline TDS in Healthy Subjects (NCT07452692) | Corium Innovations, Inc. | 2026-07-01 |
| Phase 1 Study of WBRT or PCSI With REYOBIQ for Leptomeningeal Metastases (NCT07674693) | NYU Langone Health | 2026-07-01 |
| Bioequivalence Study of GZR4 Injection With Different Manufacturing Processes in Healthy Adult Participants (NCT07670897) | Gan & Lee Pharmaceuticals. | 2026-07-01 |
| A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer (NCT07581184) | Aktis Oncology, Inc. | 2026-07-01 |
| A PHASE IB/II STUDY TO EVALUATE SAFETY AND EFFICACY OF BEXMARILIMAB IN COMBINATION WITH DOXORUBICIN IN METASTATIC SOFT-TISSUE SARCOMA (NCT07460986) | MedSIR | 2026-07-01 |
| Stimulation-based Therapy to Improve Balance in DCM (NCT07298460) | Medical College of Wisconsin | 2026-07-01 |
| A Clinical Study of TQB2930 Injection and Chemotherapy With or Without Bevacizumab in the Treatment of Advanced Colorectal Cancer (NCT07653685) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2026-07-01 |
| To Evaluate the Safety, Tolerability, Pharmacokinetics and the Effect of Food on the Hemay5259 Sustained-release Tablets in Healthy Subjects. (NCT07703904) | Hemay Pharmaceutical PTY. LTD. | 2026-07-01 |
| A Study of SI-B036 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors (NCT07678970) | Sichuan Baili Pharmaceutical Co., Ltd. | 2026-07-01 |
| A Clinical Study to Evaluate the Effect of Different Dosing Conditions on the Pharmacokinetics of HRS9531 Tablets in Healthy Participants (NCT06506175) | Fujian Shengdi Pharmaceutical Co., Ltd. | 2026-07-01 |
| Psilocybin Efficacy With or Without Pimavanserin Pretreatment (NCT07610135) | Johns Hopkins University | 2026-07-01 |
| Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma (NCT07529808) | BigHat Biosciences, Inc. | 2026-07-01 |
| Safety and Immunogenicity of a Recombinant Poliomyelitis Vaccine (rPV) in Comparison With IPOL Vaccine in Healthy Adults (NCT07688369) | Serum Institute of India Pvt. Ltd. | 2026-07-01 |
| Safety and Immunogenicity Study of IP-QSV Vaccine in Healthy Adults/Adolescents, Children and Infants (NCT07666750) | International Vaccine Institute | 2026-07-01 |
| Bio-Manguinhos/Fiocruz COVID-19 (mRNA) Vaccine Booster (NCT07640308) | The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) | 2026-07-01 |
| A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS (NCT06906471) | Antelope Surgical Solutions, Inc | 2026-07-01 |
| Study of ChoironeX GalKO Porcine Thymokidney Xenotransplantation in End-Stage Renal Disease (NCT07696962) | Xeno Holdings (US), LLC dba ChoironeX | 2026-07-01 |
| Combination Immunotherapy Targeting Sarcomas (NCT04433221) | Shenzhen Geno-Immune Medical Institute | 2026-07-01 |
| Study of GS-0415 and How It Works in People With HIV (NCT07719491) | Gilead Sciences | 2026-07-01 |
| CAN1012 in Pre-malignant Oral Dysplasia (NCT07620496) | Providence Health & Services | 2026-07-01 |
| A Study of LY4178256 in Healthy Participants (NCT07698210) | Eli Lilly and Company | 2026-07-01 |
| EMB-01 in Combination With Chemotherapy for Unresectable or Metastatic Colorectal Cancer (NCT07649655) | Shanghai EpimAb Biotherapeutics Co., Ltd. | 2026-07-01 |
| Study on Drug Interactions Affecting the Pharmacokinetics of RSS0343 Tablet (NCT07696091) | Reistone Biopharma Company Limited | 2026-07-01 |
| Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy in Diabetic Nephropathy Patients: A Clinical Trial (NCT07396155) | PT. Prodia Stem Cell Indonesia | 2026-07-01 |
| Reducing Firearm Suicide Among Veterans: Evaluating the Effectiveness of Peer-Delivered Lethal Means Counseling (NCT07033884) | VA Office of Research and Development | 2026-07-01 |